Literature DB >> 7957529

Interactions between 6-mercaptopurine therapy and thiopurine-methyl-transferase (TPMT) activity.

R Capdeville, B Mousson, G Bax, Y Bertrand, N Philippe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957529     DOI: 10.1007/BF00194412

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Importance of 6-mercaptopurine dose in lymphoblastic leukaemia.

Authors:  J P Hale; J S Lilleyman
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

2.  Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties.

Authors:  R M Weinshilboum; F A Raymond; P A Pazmiño
Journal:  Clin Chim Acta       Date:  1978-05-02       Impact factor: 3.786

3.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

Authors:  R M Weinshilboum; S L Sladek
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

4.  Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population.

Authors:  B Klemetsdal; B Straume; E Wist; J Aarbakke
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia.

Authors:  L Lennard; J S Lilleyman; J Van Loon; R M Weinshilboum
Journal:  Lancet       Date:  1990-07-28       Impact factor: 79.321

  5 in total
  2 in total

1.  Thiopurine S-methyltransferase as a target for drug interactions.

Authors:  Hua-Wen Xin; Christine Fischer; Matthias Schwab; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2005-06-11       Impact factor: 2.953

2.  Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity.

Authors:  B Klemetsdal; B Straume; R Lysaa; T Giverhaug; J Aarbakke
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.